Wealthspire Advisors (New York)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,712
| Closed | -$262K | – | 796 |
|
|
2024
Q4 | $262K | Sell |
1,712
-184
| -10% | -$28.1K | ﹤0.01% | 674 |
|
|
2024
Q3 | $368K | Sell |
1,896
-124
| -6% | -$24K | ﹤0.01% | 575 |
|
|
2024
Q2 | $468K | Sell |
2,020
-61
| -3% | -$14.1K | 0.01% | 448 |
|
|
2024
Q1 | $449K | Sell |
2,081
-299
| -13% | -$64.5K | 0.01% | 442 |
|
|
2023
Q4 | $616K | Buy |
2,380
+11
| +0.5% | +$2.85K | 0.01% | 387 |
|
|
2023
Q3 | $609K | Buy |
+2,369
| New | +$609K | 0.01% | 357 |
|
|
2023
Q1 | – | Sell |
-934
| Closed | -$259K | – | 542 |
|
|
2022
Q4 | $259K | Buy |
+934
| New | +$259K | ﹤0.01% | 485 |
|
|
2021
Q2 | – | Sell |
-1,589
| Closed | -$445K | – | 403 |
|
|
2021
Q1 | $445K | Buy |
1,589
+240
| +18% | +$67.2K | 0.01% | 427 |
|
|
2020
Q4 | $330K | Buy |
1,349
+48
| +4% | +$11.7K | 0.01% | 406 |
|
|
2020
Q3 | $369K | Buy |
1,301
+89
| +7% | +$25.2K | 0.02% | 212 |
|
|
2020
Q2 | $324K | Sell |
1,212
-2,245
| -65% | -$600K | 0.02% | 195 |
|
|
2020
Q1 | $1.09M | Buy |
3,457
+2,454
| +245% | +$777K | 0.05% | 180 |
|
|
2019
Q4 | $298K | Buy |
1,003
+94
| +10% | +$27.9K | 0.02% | 148 |
|
|
2019
Q3 | $212K | Buy |
+909
| New | +$212K | 0.02% | 152 |
|
|
2019
Q1 | – | Sell |
-189
| Closed | -$57K | – | 138 |
|
|
2018
Q4 | $57K | Buy |
+189
| New | +$57K | 0.01% | 167 |
|